Led through the Medical AI Data for All (MAIDA) initiative at Harvard Medical School, the study explored ways to adapt existing AI technologies to neonatal care without requiring hospitals to share patient imaging data centrally.
QPHI will work with Sidra Medicine to shape the summit’s scientific programme and strengthen discussions on translating genomic research into clinical applications and preventive healthcare.
Although genome sequencing has expanded worldwide, scientists still lack a clear understanding of how many genetic variations affect gene activity and contribute to disease.
The multidisciplinary project combines archaeology, radiology and molecular research to examine human remains recovered from Umm Al Maa and Al Kharsaah, with international research institutions contributing expertise.
The two-day conference brought together international scientists and healthcare professionals to discuss the role of the microbiome in disease, advances in rapid metagenomics, antimicrobial resistance (AMR), and new approaches to predicting and managing sepsis.
A key announcement was the launch of QMicrobe, a programme designed to establish Qatar’s first dedicated paediatric donor stool bank for therapeutic research.
The key topics that will be covered will include diabetes technology, early intervention for type 1 diabetes, childhood obesity, precision medicine and therapies for rare endocrine conditions.
Neuroblastoma is a cancer that develops in immature nerve cells and most commonly affects infants and young children.
The Pediatric Private Home Visits: Wellness and Vaccinations program covers routine services that support children’s health and development.
Over the past five years, the program has expanded its molecular diagnostic capabilities and introduced expedited genomic oncology profiling to provide oncologists with timely information when treatment decisions are urgent.